News

To register for the showcase, click here. Please contact your A.G.P. representative to schedule a one-on-one investor meeting with the PDS Biotech leadership team. Following the event, an archived ...
Shift Bioscience, a Cambridge-based biotech company using an AI powered virtual cell to fight age-driven diseases, has ...
During the presentation, Dr. Beetham will discuss the Company's progress in advancing its gene-editing technology platform, recent regulatory developments supporting agricultural innovation, and Cibus ...
Medicxi’s stripped-back approach has undoubtedly influenced Z Factor’s “virtual biotech company” set-up. This means it has no internal operations, and instead using a network of out ...
Fortress Biotech, Inc. (“Fortress”) is an innovative biopharmaceutical company focused on acquiring and advancing assets to enhance long-term value for shareholders through product revenue ...
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said ...
“The use of a ‘virtual human twin’ for medical research ... Skourides underlined that the Cypriot nano-biotechnology company EPOS – IASIS, for example, recently participated in a cutting ...
Bio-Gene Technology Limited announced its participation in the NWR Virtual Healthcare Conference 2025, where CEO Tim Grogan will present the company’s advancements in bio-insecticides.
The founder of a successful public biotechnology company once told me that the secret to his company's success was neither the idea nor the concept, but the management team: from day one the ...
2:00 p.m. – 2:30 p.m. ET: Fireside Chat 5:00 p.m. – 6:00 p.m. ET: Panel Presentation: Development Stage Companies – Where Do Royalty and Tech Platform Plays Fit? To register for the ...